Floatz logo

Oxygen

Cluster Headache Syndrome

The University of Texas Health Science Center, HoustonSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Cluster Headache Syndrome cohort.

Asset / SponsorPhaseRating
Galcanezumab
Eli Lilly and Company
Phase 3BB
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer
Charite University, Berlin, Germany
Phase 2B
Marcaine
Stanford University
Phase 2CCC
Pasireotide
Novartis Pharmaceuticals
Phase 2CCC
Dexasone
Weill Medical College of Cornell University
Phase 1CC

View all 9 →

Same molecule, other indications

Oxygen is also rated in:

anxiety disorderActive
BB
Indicative · Phase 4
66 / 100
View asset →
benign prostatic hyperplasiaActive
BB
Indicative · Phase 4
66 / 100
View asset →
prostate disorderActive
BB
Indicative · Phase 4
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →